Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Biomed Res Int ; 2021: 6679082, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34195278

RESUMEN

The aim of our study was to investigate the effects of single-dose Ougan (Citrus reticulata cv. Suavissima) juice application on the pharmacokinetics of erlotinib in vivo. Twelve Sprague-Dawley rats were randomly divided into the Ougan juice and control groups (n = 6 each). The rats were given a single dose of 1 mL/100 g Ougan juice or 1 mL/100 g normal saline (NS) by intragastric administration, followed by a single oral administration of 20 mg/kg erlotinib. The plasma concentration of erlotinib in rats was determined using ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Erlotinib-d6 was used as the internal standard for chromatographic analysis on the UPLC BEH C18 analysis column (2.1 mm × 50 mm, 1.7 µm). The mobile phase was composed of acetonitrile and 0.1% formic acid eluting by gradient. Different pharmacokinetic (PK) parameters of erlotinib were calculated. The Ougan juice promoted the absorption of erlotinib and reduced the clearance of the drug. The area under the curve of erlotinib in the single-dose Ougan juice pretreatment group was approximately 1.87 times higher, and the maximum blood concentration (Cmax) was approximately 1.34 times higher than that in the control group. The mean residence time of erlotinib in the Ougan juice group was larger, and the clearance rate was smaller than those in the control group; the difference was statistically significant (P < 0.05). Ougan juice affected the PK spectrum of erlotinib in rats by improving the bioavailability of the drug and significantly increasing its plasma concentration.


Asunto(s)
Citrus/metabolismo , Clorhidrato de Erlotinib/farmacocinética , Jugos de Frutas y Vegetales , Animales , Cromatografía Liquida , Citocromo P-450 CYP3A/metabolismo , Interacciones Farmacológicas , Clorhidrato de Erlotinib/sangre , Ratas , Ratas Sprague-Dawley , Reproducibilidad de los Resultados , Estómago/efectos de los fármacos , Espectrometría de Masas en Tándem
2.
Artículo en Zh | WPRIM | ID: wpr-271860

RESUMEN

Research development of germplasm resources of Salvia miltiorrhiza was reviewed in the aspects of species resource, geographic distribution and varieties, biological characters and culture varieties, and cell and tissue culture. It was suggested that more attention be paid to waters-soluble constituents when evaluating the quality of the medicine, and much more basic studies be done in the course of establishing standard plant base for high quality herb and in the aspect of new variety selection.


Asunto(s)
Conservación de los Recursos Naturales , Técnicas de Cultivo , Abietanos , Medicamentos Herbarios Chinos , Ecología , Fenantrenos , Plantas Medicinales , Química , Control de Calidad , Salvia , Química , Clasificación , Salvia miltiorrhiza , Química , Suelo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA